Treatise on Ocular Drug Delivery
Ashim K. Mitra, Xiaoyan Yang, Kay D. Rittenhouse, Ann-Marie Ako-Adouno, Gyan Prakash Mishra, Jwala Renukuntla(High Point University), Ketan Hippalgaonkar, Mitesh Patel, Animikh Ray, Uday B. Kompella, Sujay Shah, Deep Kwatra(University of Kansas Medical Center), Pradeep K. Karla(Howard University), Aswani Dutt Vadlapudi, Megha Barot, Sulabh Patel, Walter G. Chambliss, Sai H. S. Boddu(University of Toledo), Tushar Hingorani, Ramya Krishna Vadlapatla, Aarika L. Menees, Varun Khurana, Ashish Thakur(Agricultural Institute), Dhananjay Pal(University of Missouri–Kansas City), Soumyajit Majumdar(University of Mississippi), Ashaben Patel(University of Missouri–Kansas City), Ripal Gaudana(University of Missouri–Kansas City), Harisha Atluri, Viral Tamboli
Unknown
January 30, 2018
Cited by 2
Related Papers
Recent Perspectives in Ocular Drug Delivery
|Pharmaceutical Research|2008|596
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
|Pharmaceutics|2018|408
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
|International Journal of Molecular Sciences|2021|157
Methanolic Extracts of Bitter Melon Inhibit Colon Cancer Stem Cells by Affecting Energy Homeostasis and Autophagy
|Evidence-based Complementary and Alternative Medicine|2013|72